MedImpact and GoodRx are teaming up to lower costs for MedImpact members. When eligible MedImpact members refill a generic prescription, the companies' savings solution will compare the member's benefit to GoodRx's price and will automatically apply the lowest one.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Medicine Cabinet, a new solution by GoodRx, gives users reminders to take their medications and refill prescriptions and recommends pharmacies based on prescription costs. It also has a rewards system for using GoodRx coupons and picking up prescriptions on time.
CVS Caremark and GoodRx created a new program called Caremark Cost Saver, which will become available starting January 1, 2024. Through the program, eligible CVS Caremark commercially insured members will have access to GoodRx’s prescription pricing on generic medications.
Three senators recently introduced legislation that would ban the use of health data for advertising and marketing purposes. The proposed legislation comes amid media reports claiming that data brokers are selling social media companies patients' location data, as well as reports that hospitals and digital health startups are collecting patients’ online data and sharing it with tech giants such as Facebook and Google.
GoodRx failed to notify users that it sold their personal health information to Google, Facebook and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users' data with third parties for advertising purposes and requires the company to pay a $1.5 million penalty. GoodRx agreed to pay the settlement but did not admit to wrongdoing.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Check out new developments from Opala, Wheel, GoodRx, Fathom, Tivic Health, and more.
GoodRx is arguably most well-known for its search platform that allows consumers to compare drug prices across different pharmacies. Now, it has launched a similar platform for healthcare providers. The new platform, called “Provider Mode,” is designed to help providers search for drug cost information while they are conducting appointments with their patients.
Specialty drugs reportedly reached 50 percent of all drug spending in 2020, a figure that has increased significantly over the last decade.
In over 20% of U.S. counties, most people have to drive more than 30 minutes to reach the closest hospital, making them hospital desert areas, according to a recent report. Large swathes of the country are also pharmacy and trauma center deserts.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Several pharmacies signed a letter asking Surescripts’ board to rescind its deal with GoodRx. They said the deal would not reveal the true cost of medications, and might steer patients away from independent pharmacies.
The agreement would provide prescribing healthcare providers with information in their EMR about GoodRx's cash discount pricing for patients who are uninsured or where insurance pricing isn't available.
In a month where GoodRx’s stock has been trading below IPO levels, the startup’s leadership says Amazon Pharmacy still isn’t a threat. Citing third-party data, the company said uptake of Amazon's pharmacy services have been low, though the retailer still could pose a threat with its growing healthcare business.
GoodRx began trading on Nasdaq in an upsized IPO. The company priced its stock at $33 per share, up from its expected range of $24 to $28 per share.
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.